Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Biotech is in ‘a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
12:10pm, Sunday, 22'nd May 2022 MarketWatch
Watch for these 3 catalysts and consider these 6 stocks.
3 Biotech Stocks With a Cash Pile Higher Than Their Valuations
12:00pm, Saturday, 21'st May 2022 The Motley Fool
Our roundtable found three biotechs with a nice cash cushion.
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer
06:17pm, Friday, 20'th May 2022 Zacks Investment Research
Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.
Bristol-Myers Squibb: A Safe Haven In Times Of Uncertainty
06:06pm, Friday, 20'th May 2022
Geopolitics and risk of economic recession in the U.S. is forcing investors to look for defensive stocks, which refer to health care sector. Healthcare stocks are protected during the recession by bot
3 Health Care Stocks To Watch Right Now
12:30pm, Friday, 20'th May 2022
Could these health care stocks be safe bets in the stock market today?
This Safe Stock Is Dirt Cheap -- and It's Beating the Market
12:03pm, Friday, 20'th May 2022 The Motley Fool
There's a lot to like about this big pharma juggernaut.
Bombshell 13F Filing: Michael Burry Is Short Apple Stock
04:57pm, Wednesday, 18'th May 2022 Seeking Alpha
Michael Burry (of the Big Short fame) has shorted Apple via put options. Read more about Burry's move and what this could mean for AAPL stock.
3 Stocks Up 25% to 65% That Are Still Smart Buys
03:44pm, Wednesday, 18'th May 2022 The Motley Fool
These high-flying stocks could continue soaring.
Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates
03:41pm, Wednesday, 18'th May 2022 Zacks Investment Research
Regulatory updates and acquisition news from Bristol Myers' (BMY) and BridgeBio Pharma (BBIO) are a few key highlights from the biotech sector during the past week.
Michael Burry (Of 'The Big Short') Piles Into Big Tech Names, Value Investments
12:14pm, Wednesday, 18'th May 2022 Seeking Alpha
Michael Burry sold all of his previous positions except for one, Bristol-Myers Squibb. Read this article to know more about his new positions.
3 Stocks Up 25% to 65% That Are Still Smart Buys
11:44am, Wednesday, 18'th May 2022
These high-flying stocks could continue soaring.
Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints
03:33pm, Tuesday, 17'th May 2022 Zacks Investment Research
Bristol Myers (BMY) phase III CheckMate -901 study fails to meet the primary endpoint of overall survival in patients with untreated unresectable or metastatic urothelial cancer.
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
03:00pm, Tuesday, 17'th May 2022 The Motley Fool
With thrilling long-term prospects, these three are excellent buys.
Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints
12:47pm, Tuesday, 17'th May 2022
Bristol Myers (BMY) phase III CheckMate -901 study fails to meet the primary endpoint of overall survival in patients with untreated unresectable or metastatic urothelial cancer.
2 Biotech Stocks That Could Go Parabolic
12:30pm, Monday, 16'th May 2022 The Motley Fool
These gems are hiding in a sector that has been pummeled so far this year.
